{"version":"1.0","type":"card","id":"baa966b1-5b12-4f39-a4da-dbd55a515d38","url":"https://stacklist.com/card/baa966b1-5b12-4f39-a4da-dbd55a515d38","title":"The Two Genes Behind Your Caffeine Response","source_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC6213712/","note":"Review in Nutrients: CYP1A2 controls most caffeine metabolism, and ADORA2A is linked to caffeine-induced anxiety. Together they explain why the same dose hits people differently.","image":{"url":"https://ucarecdn.com/9296d7a3-8316-4577-b7cf-0d8784214280/","alt":"The Two Genes Behind Your Caffeine Response","width":1920,"height":1275},"stack":{"id":"f6aa32b1-01bd-4395-97c5-7c5859b62441","title":"Why Your Coffee Stopped Working: LSC100 + Caffeine Tolerance & Genetics","url":"https://stacklist.com/c/wellness/stack/f6aa32b1-01bd-4395-97c5-7c5859b62441"},"created_at":"2026-11-17T01:37:20.875Z","updated_at":"2026-11-17T01:42:36.875Z","aco":{"summary":"The Role of Genetics in Moderating Inter-Individual Differences in Caffeine Ergogenicity examines how two genes, CYP1A2 and ADORA2A, significantly influence individual responses to caffeine supplementation in athletic performance. CYP1A2 controls caffeine metabolism while ADORA2A is linked to caffeine-induced anxiety, and understanding these genetic factors can help tailor caffeine supplementation programs for individual athletes.","tags":["caffeine-metabolism","genetics","ergogenic-effects","CYP1A2","ADORA2A","exercise-performance","sports-supplementation"],"key_entities":[{"name":"CYP1A2","type":"concept","confidence":0.99},{"name":"ADORA2A","type":"concept","confidence":0.99},{"name":"caffeine-metabolism","type":"concept","confidence":0.98},{"name":"Kyle Southward","type":"person","confidence":0.95},{"name":"Kay Rutherfurd-Markwick","type":"person","confidence":0.95},{"name":"Claire Badenhorst","type":"person","confidence":0.95},{"name":"Ajmol Ali","type":"person","confidence":0.95},{"name":"Massey University","type":"organization","confidence":0.98},{"name":"World Anti-Doping Agency","type":"organization","confidence":0.97},{"name":"Auckland","type":"location","confidence":0.96},{"name":"New Zealand","type":"location","confidence":0.96},{"name":"ergogenic-effects","type":"concept","confidence":0.98}],"classification":"reference","language":"en","confidence":0.85,"provenance":{"model":"claude-haiku-4-5","tool":"@stacklist/mcp-server@2.0.0","confidence":0.85,"timestamp":"2026-11-17T01:37:26.638Z"},"token_counts":{"approximate":14042,"cl100k":15148},"content_hash":"sha256:72ec1a8922ff82afd8f433f96177b21ec379f727021cc7af7b07d67e8fa3f8b8","acp_version":"0.2","body_available":false,"body_tokens":0,"visibility":"public","agent_accessible":true,"status":"final"},"_links":{"self":"/api/public/card/baa966b1-5b12-4f39-a4da-dbd55a515d38.json","html":"https://stacklist.com/card/baa966b1-5b12-4f39-a4da-dbd55a515d38","md":"/api/public/card/baa966b1-5b12-4f39-a4da-dbd55a515d38.md","stack_json":"/api/public/stack/f6aa32b1-01bd-4395-97c5-7c5859b62441.json"}}